Allergan PLC (AGN)

AGN (NYSE:Drugs) EQUITY
$247.11
pos +2.72
+1.11%
Today's Range: 243.87 - 249.44 | AGN Avg Daily Volume: 2,260,700
Last Update: 06/22/17 - 4:01 PM EDT
Volume: 2,718,070
YTD Performance: 13.63%
Open: $244.88
Previous Close: $244.39
52 Week Range: $184.50 - $261.27
Oustanding Shares: 335,867,027
Market Cap: 80,147,948,653
6-Month Chart
TheStreet Ratings Grade for AGN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 8 8 10 10
Moderate Buy 3 3 3 3
Hold 3 2 3 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.61 1.50 1.53 1.62
Latest Dividend: 0.70
Latest Dividend Yield: 1.17%
Dividend Ex-Date: 05/16/17
Price Earnings Ratio: -22.49
Price Earnings Comparisons:
AGN Sector Avg. S&P 500
-22.49 7.90 30.50
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.71% 5.55% 10.02%
GROWTH 12 Mo 3 Yr CAGR
Revenue -3.30 0.70 0.19
Net Income 282.20 0.20 0.00
EPS 281.40 -8.20 0.00
Earnings for AGN:
EBITDA 5.58B
Revenue 14.57B
Average Earnings Estimates
Qtr (06/17) Qtr (09/17) FY (12/17) FY (12/18)
Average Estimate $3.98 $4.19 $16.10 $18.09
Number of Analysts 15 15 16 16
High Estimate $4.19 $4.26 $16.23 $18.60
Low Estimate $3.76 $4.03 $16.00 $17.53
Prior Year $3.35 $3.32 $13.51 $16.10
Growth Rate (Year over Year) 18.95% 26.10% 19.18% 12.38%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
RMPIA
By

Doug Kass

 | Jun 22, 2017 | 1:04 PM EDT
Getting larger in Apple (AAPL) short at $146.25. With sales at $249.25 I am down to tag ends in Allergan  (AGN) . (Hopefully I will b …
RMPIA
By

Doug Kass

 | Jun 22, 2017 | 11:40 AM EDT
As Allergan (AGN) approaches $250 resistance, I continue to pare down -- sold some more at $248.75.   But, I'll be baack! …
RMPIA
By

Doug Kass

 | Jun 22, 2017 | 10:25 AM EDT
Six months ago today I placed Allergan (AGN) on my Best Ideas List at $194. At the time I had a price target of about $270, which later wa …
RMPIA
By

Doug Kass

 | Jun 22, 2017 | 9:50 AM EDT
I'm selling down some more Allergan (AGN) at $245.50 to $246.00 as the biotech rotation provides an opportunity after a $30 move higher fr …
RMPIA
By

Doug Kass

 | Jun 22, 2017 | 7:12 AM EDT
"For a day where the S&P was essentially flat, there was a lot going on beneath the surface.
RMPIA
By

Doug Kass

 | Jun 20, 2017 | 3:41 PM EDT
"Just one more thing." -- Lt. Columbo Reflecting the magnitude of the recent move from the lows (+$20) (and the adoption of sudden o …
RMPIA
By

Doug Kass

 | Jun 20, 2017 | 10:21 AM EDT
" Who loves ya?"  -- Kojak   Allergan (AGN) shares are now up more than $20 from its recent lows.   W …
RMPIA
By

Jim Cramer

 | Jun 20, 2017 | 5:18 AM EDT
I think caution is warranted if we rally again like this.
RMPIA
By

Bruce Kamich

 | Jun 19, 2017 | 2:39 PM EDT
Prices have rallied since late May.
RMPIA
By

Doug Kass

 | Jun 15, 2017 | 6:45 PM EDT
Mr. Market embarked on an all-too-familiar rally from the early morning lows today, closing near its intraday high. 
our chart of the week worked out nicely! we'll bank this big winner and roll up SOLD ...
No news yet, but Ralph Lauren (RL) is surging in early trading.

...
Good morning. Just a few comments about stocks that are in the news. Forget what I said...
Just what is the Fed thinking about these days?  Let's talk about it at 130pm PST (43...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.